Bank of New York Mellon
OCAT

Bank of New York Mellon’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bank of New York Mellon’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-138,438
Closed -$1.17M – 4366
2015
Q4 		$1.17M Buy
138,438
+9,967
+8% +$66.7K ﹤0.01% 3065
2015
Q3 		$537K Buy
128,471
+32,639
+34% +$143K ﹤0.01% 3551
2015
Q2 		$505K Buy
+95,832
New +$614K ﹤0.01% 3634

Bank of New York Mellon's OCAT Position: Q1 2016 in Review

Bank of New York Mellon sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 138,438 shares — an estimated $1.17M sold.

Bank of New York Mellon first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $1.17M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Bank of New York Mellon reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 138,438 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $1.17M.
  • Bank of New York Mellon first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Bank of New York Mellon's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $1.17M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Bank of New York Mellon's 13F filing for Q1 2016, filed 11 May 2016.